BRIAN GASHLER: Open Payments
NPI 1144705583 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 23 payments from 9 companies in 2025. Trend: 2023 $495 · 2024 $333 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $224 |
| ABBVIE INC. | 4 | $77 |
| Biogen, Inc. | 3 | $73 |
| Indivior Inc. | 2 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Lundbeck LLC | 1 | $27 |
| Tempus AI, Inc | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: SPRAVATO, VRAYLAR, ZURZUVAE, SUBLOCADE, COBENFY, REXULTI, XT CDX, FANAPT.
Industry payments across UT — which companies pay providers there.
